mifepristone has been researched along with metribolone in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, C; Du, X; Eksterowicz, J; Fantin, VR; Huang, E; Huang, T; Jackson, E; Jahchan, N; Kawai, H; McGee, LR; Medina, JC; Rew, Y; Sun, D; Sutimantanapi, D; Waszczuk, J; Yan, X; Ye, Q; Zavorotinskaya, T; Zhou, H; Zhu, L | 1 |
Berrevoets, CA; Brinkmann, AO; Umar, A | 1 |
Agoulnik, IU; Amrikachi, M; Ayala, GE; Bingman, WE; Krause, WC; Rahman, HT; Weigel, NL | 1 |
Berrevoets, CA; Brinkmann, AO; Trapman, J; Umar, A | 1 |
Chang, CY; Elbi, C; Hager, GL; Hendarwanto, A; Klokk, TI; Kurys, P; Nagaich, AK; Saatcioglu, F; Slagsvold, T | 1 |
Cai, Y; Conzen, SD; Isikbay, M; Kach, J; Kregel, S; Otto, K; Szmulewitz, RZ; Vander Griend, DJ | 1 |
1 review(s) available for mifepristone and metribolone
Article | Year |
---|---|
Antiandrogens: selective androgen receptor modulators.
Topics: Androgen Antagonists; Androgens; Animals; Cell Line; Gene Expression Regulation; Humans; Male; Metribolone; Mifepristone; Protein Binding; Receptors, Androgen | 2002 |
5 other study(ies) available for mifepristone and metribolone
Article | Year |
---|---|
Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101).
Topics: Animals; Drug Discovery; Female; Hormone Antagonists; Humans; Mice; Ovarian Neoplasms; Rats; Receptors, Glucocorticoid; Swine; Swine, Miniature; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Repressors of androgen and progesterone receptor action.
Topics: Animals; Binding Sites; Breast Neoplasms; COS Cells; DAX-1 Orphan Nuclear Receptor; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Hormone Antagonists; Humans; Hydroxamic Acids; Male; Metribolone; Mifepristone; Nuclear Proteins; Nuclear Receptor Co-Repressor 1; Nuclear Receptor Co-Repressor 2; Promoter Regions, Genetic; Prostate; Prostatic Hyperplasia; Protein Structure, Tertiary; Protein Synthesis Inhibitors; Receptors, Androgen; Receptors, Calcitriol; Receptors, Interferon; Receptors, Progesterone; Receptors, Retinoic Acid; Repressor Proteins; Testosterone Congeners; Tumor Suppressor Protein p53 | 2003 |
Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Animals; Binding, Competitive; Cell Line, Tumor; CHO Cells; Cricetinae; Cyproterone Acetate; Down-Regulation; Gene Expression Regulation; Ligands; Male; Metribolone; Mice; Mifepristone; Mutation; Nuclear Proteins; Nuclear Receptor Co-Repressor 1; Nuclear Receptor Coactivator 2; Promoter Regions, Genetic; Prostatic Neoplasms; Receptors, Androgen; Repressor Proteins; Transcription Factors; Transcription, Genetic; Transfection | 2004 |
Ligand-specific dynamics of the androgen receptor at its response element in living cells.
Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Animals; Cell Line, Tumor; Chromatin Assembly and Disassembly; Cyproterone Acetate; Dihydrotestosterone; Female; Fluorescence Recovery After Photobleaching; Flutamide; Genes, Reporter; Green Fluorescent Proteins; In Situ Hybridization, Fluorescence; Ligands; Luciferases; Mammary Neoplasms, Animal; Mammary Tumor Virus, Mouse; Metribolone; Mice; Microscopy, Video; Mifepristone; Models, Biological; Nitriles; Plasmids; Promoter Regions, Genetic; Receptors, Androgen; Response Elements; Testosterone; Tosyl Compounds; Transcription, Genetic | 2007 |
Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzoates; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Survival; Dexamethasone; Drug Resistance, Neoplasm; HEK293 Cells; Humans; Immediate-Early Proteins; Immunoblotting; Male; Metribolone; Mice; Mice, Nude; Microscopy, Fluorescence; Mifepristone; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Receptors, Androgen; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Xenograft Model Antitumor Assays | 2014 |